Abstract:Genetic susceptibility seems to play an important role in some gastric cancers. In some rare cases, gastric cancer can be one part of familial cancer syndromes. A well-known example is the family of Napoleon since the Emperor himself as well as his father and his grandfather had gastric cancer. Generally, hereditary factors include germline mutations of E-cadherin, APC, p53 or mismatch repair genes like hMLH1 or hMSH2. Gatekeeper genes like Ecadherin and APC encode signaling proteins important to cellular proliferation and differentiation while protein products from caretaker genes like p53 or mismatch repair genes are important to maintain the integrality and fidelity of the genome. In addition to gene mutations, gene polymorphisms have been shown to be associated with the susceptibility of gastric cancer (El-Omar et al., 2000; Persson et al., 2011). Interestingly, most of these genes are encoding proinflammatory cytokines, strongly indicating the importance of inflammation to the initiation and progression of gastric cancer. Environment factors play important roles in the pathogenesis of gastric cancer by affecting the inflammation in the stomach. The infection of Helicobacter pylori is apparently one of the primary risk factors of gastric cancer. In 1994, the World Health Organization and the International Agency for Research on Cancer Consensus group classified H. pylori as a type I carcinogen in human beings. Although numerous studies reported the growth promoting effect of H. pylori or its derived proteins in vitro, no direct evidence about the interaction of H. pylori with cancer initiating or stem cells have been presented. In contrast, accumulating reports indicated that the inflammation induced by H. pylori infection is the key to gastric carcinogenesis. Thus, it was believed that H. pylori infection is the initial step in the stepwise process of gastric carcinogenesis starting from chronic gastritis, gastric atrophy, intestinal metaplasia, dysplasia to gastric carcinoma. Consistently, diets rich in fruit and vegetables is protective factors of gastric cancer since vitamin C are helpful to attenuate inflammation while inflammation-promoting factors such as smoking, foods with high salts and nitrite could facilitate the development of gastric cancer by promoting chronic inflammation. Microenvironments in chronic inflammatory tissues are rich in growth factors and cytokines important to promote the perpetuation of tumor growth by epigenetically reprogramming cancer stem cells. In addition, there are some DNA damage inducing agents such as reactive oxygen and nitrogen species (RONS) that can cause genomic alterations, promoting the accumulation of mutations in proliferating cancer stem cells (Meira et al., 2008). On the other

Injury, repair, inflammation and metaplasia in the stomach.

Cellular Plasticity, Reprogramming, and Regeneration: Metaplasia in the Stomach and Beyond

Role of metaplasia during gastric regeneration

Single-cell transcriptional analyses of spasmolytic polypeptide-expressing metaplasia arising from acute drug injury and chronic inflammation in the stomach

Single-Cell Transcriptional Analyses Identify Lineage-Specific Epithelial Responses to Inflammation and Metaplastic Development in the Gastric Corpus

Role of Spasmolytic Polypeptide-Expressing Metaplasia in Gastric Mucosal Diseases.

The mechanisms of gastric mucosal injury: focus on initial chief cell loss as a key target

The composition and roles of gastric stem cells in epithelial homeostasis, regeneration, and tumorigenesis

Helicobacter pylori plays a key role in gastric adenocarcinoma induced by spasmolytic polypeptide-expressing metaplasia

Acid and the basis for cellular plasticity and reprogramming in gastric repair and cancer

Evidence for Heightened Genetic Instability in Precancerous Spasmolytic Polypeptide Expressing Gastric Glands

Gastric intestinal metaplasia: progress and remaining challenges

UNVEILING CANCER-RELATED METAPLASTIC CELLS IN BOTH HELICOBACTER PYLORI INFECTION AND AUTOIMMUNE GASTRITIS

Role and research progress of spasmolytic polypeptide‐expressing metaplasia in gastric cancer (Review)

The Epigenetic Aspects of Gastric Cancer

Acid, bile, and CDX: the ABCs of making Barrett's metaplasia

Metaplastic regeneration in the mouse stomach requires a reactive oxygen species pathway

Interleukin 13 Promotes Maturation and Proliferation in Metaplastic Gastroids

Regulation of metaplasia and dysplasia in the stomach by the stromal microenvironment

H. Pylori‐Facilitated TERT/Wnt/β‐Catenin Triggers Spasmolytic Polypeptide‐Expressing Metaplasia and Oxyntic Atrophy

Global knowledge mapping and emerging trends in research between spasmolytic polypeptide-expressing metaplasia and gastric carcinogenesis: A bibliometric analysis from 2002 to 2022